Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Non-cash Items (2016 - 2018)

Historic Non-cash Items for Sangamo Therapeutics (SGMO) over the last 9 years, with Q4 2018 value amounting to $3.7 million.

  • Sangamo Therapeutics' Non-cash Items fell 9483.78% to $3.7 million in Q4 2018 from the same period last year, while for Dec 2018 it was $3.7 million, marking a year-over-year decrease of 9483.78%. This contributed to the annual value of $3.7 million for FY2018, which is 9483.78% down from last year.
  • Per Sangamo Therapeutics' latest filing, its Non-cash Items stood at $3.7 million for Q4 2018, which was down 9483.78% from $71.7 million recorded in Q4 2017.
  • Over the past 5 years, Sangamo Therapeutics' Non-cash Items peaked at $71.7 million during Q4 2017, and registered a low of $3.7 million during Q4 2018.
  • Its 5-year average for Non-cash Items is $27.4 million, with a median of $6.0 million in 2016.
  • As far as peak fluctuations go, Sangamo Therapeutics' Non-cash Items surged by 108745.85% in 2017, and later crashed by 9483.78% in 2018.
  • Quarter analysis of 5 years shows Sangamo Therapeutics' Non-cash Items stood at $50.8 million in 2014, then crashed by 90.25% to $5.0 million in 2015, then rose by 21.89% to $6.0 million in 2016, then surged by 1087.46% to $71.7 million in 2017, then crashed by 94.84% to $3.7 million in 2018.
  • Its Non-cash Items stands at $3.7 million for Q4 2018, versus $71.7 million for Q4 2017 and $6.0 million for Q4 2016.